An efficient procedure for the synthesis of 3-cyano-4-difluoromethyl- and 3-cyano-4-trifluoromethyl-2(1H)-pyridones was developed. The structure of one of the resulting compounds was established by X-ray diffraction analysis.
[EN] INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS<br/>[FR] INDAZOLES ET AZAINDAZOLES EN TANT QU'INHIBITEURS DE LRRK2
申请人:ESCAPE BIO INC
公开号:WO2021178780A1
公开(公告)日:2021-09-10
The present invention is directed to indazole and azaindazole compounds which are inhibitors of LRRK2 and are useful in the treatment of CNS disorders.
本发明涉及一种抑制LRRK2的吲唑和杂氮吲唑化合物,可用于治疗中枢神经系统疾病。
——
作者:K. I. Pashkevich、D. V. Sevenard、O. G. Khomutov、I. I. Vorontsov
DOI:10.1023/a:1011317013265
日期:——
An efficient procedure for the synthesis of 3-cyano-4-difluoromethyl- and 3-cyano-4-trifluoromethyl-2(1H)-pyridones was developed. The structure of one of the resulting compounds was established by X-ray diffraction analysis.